IPO
Went public as Eliem Therapeutics, Inc. Priced at US$12.50 a share on Aug 9, 2021.
- Price
- US$12.50 a share
- Shares offered
- 6,400,000 shares of common stock
- Offering size
- US$80 million
- Underwriters' option
- Up to 960,000 more shares
- Underwriters
- SVB Leerink, Evercore ISI, Stifel, Guggenheim Securities · In the order on the cover
Steps
| Step | When |
|---|
| Draft sent to the SEC in confidence | May 12, 2021 |
|---|
| Filed publicly | Jul 16, 2021 |
|---|
| Amended 4 times | Newest Aug 9, 2021 |
|---|
| Shares registered with an exchange | Aug 3, 2021 |
|---|
| Declared effective by the SEC | Aug 9, 2021 |
|---|
| Final prospectus, with the price | Aug 11, 2021 |
|---|
Filings
| Filing | Filed |
|---|
| 424B4 · Prospectus | Aug 11, 2021 |
|---|
| EFFECT · Notice that a registration is effective | Aug 9, 2021 |
|---|
| S-1MEF · Registration of more shares for the same offering | Aug 9, 2021 |
|---|
| S-1/A · Registration statement, amended | Aug 9, 2021 |
|---|
| CORRESP · Letter to the SEC | Aug 9, 2021 |
|---|
| CORRESP · Letter to the SEC | Aug 9, 2021 |
|---|
| FWP · Free writing prospectus | Aug 9, 2021 |
|---|
| S-1/A · Registration statement, amended | Aug 9, 2021 |
|---|
| CERT · Exchange's certificate of listing | Aug 5, 2021 |
|---|
| CORRESP · Letter to the SEC | Aug 5, 2021 |
|---|
| CORRESP · Letter to the SEC | Aug 4, 2021 |
|---|
| CORRESP · Letter to the SEC | Aug 4, 2021 |
|---|
| CORRESP · Letter to the SEC | Aug 3, 2021 |
|---|
| 8-A12B · Registration of shares for listing on an exchange | Aug 3, 2021 |
|---|
| S-1/A · Registration statement, amended | Aug 3, 2021 |
|---|
| UPLOAD · Letter from the SEC | Aug 2, 2021 |
|---|
| S-1/A · Registration statement, amended | Aug 2, 2021 |
|---|
| CORRESP · Letter to the SEC | Jul 28, 2021 |
|---|
| S-1 · Registration statement | Jul 16, 2021 |
|---|
| DRSLTR · Letter to the SEC with a draft | Jul 12, 2021 |
|---|
| DRS/A · Draft registration statement, amended | Jul 12, 2021 |
|---|
| UPLOAD · Letter from the SEC | Jul 6, 2021 |
|---|
| DRSLTR · Letter to the SEC with a draft | Jun 21, 2021 |
|---|
| DRS/A · Draft registration statement, amended | Jun 21, 2021 |
|---|
| UPLOAD · Letter from the SEC | Jun 9, 2021 |
|---|
| DRS · Draft registration statement | May 12, 2021 |
|---|
From the cover of the final prospectus (424B4) filed Aug 11, 2021